Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Sanmar Group is a diversified Indian conglomerate with a significant presence in the global specialty chemicals and pharmaceutical sectors. Through its subsidiary, Chemplast Sanmar, the group operates a robust Contract Development and Manufacturing Organization (CDMO) that provides end-to-end solutions for the life sciences industry. Their expertise encompasses complex organic synthesis, process R&D, and the commercial-scale production of advanced intermediates and Active Pharmaceutical Ingredients (APIs). The company is distinguished by its ability to handle hazardous chemical processes and high-pressure reactions in cGMP-compliant facilities. With a strong commitment to intellectual property protection and quality, Sanmar serves as a strategic partner to major pharmaceutical and agrochemical companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanmar Group.